David Ramsay

Mr. Speaker, I asked specifically about the Arepanrix H1N1 vaccine. Again, this is very confusing for people, confusing for me, confusing for the general public, because if you go to the product information leaflet on Arepanrix H1N1 right off of the Health Canada website, it says right here in healthy adults, aged 18 to 60 years and no -- I repeat no -- clinical experience yet in elderly, in children or in adolescents. What they did is use a different testing model on children and adolescents and the elderly. They didn’t use this. This vaccine has not, to my knowledge off the Health Canada...

Mr. Speaker, the Minister forgot to say one of the ingredients on the list and that was formaldehyde. I would like to add that for her.

The other question I have, Mr. Speaker, on the Department of Health’s H1N1 flu site, it says at the end: “MYTH: because H1N1 vaccine is new, it is untested and unsafe. FACT:” -- and at the end of that statement it says -- “and no safety concerns have been found.” The reason, Mr. Speaker, I bring this up is because it is confusing for people out there when they do go to the Health Canada website and they see some of what are the side effects: very common; common...

Mr. Speaker, again, that is a nice story. I am glad people are getting their shot, but the question I had for the Minister was: at the multiplex today were there product information leaflets available to the public who are getting their shot that clearly indicates every ingredient in that vaccine, Mr. Speaker? By the sounds of it, people have to ask what is in it. I don’t think that is appropriate. I think that we should be providing the public with that type of information. I would like to ask the Minister, if that isn’t the case, if she could provide that level of information to our...

Thank you, Mr. Speaker. Today marks the first day of a mass vaccination against the spread of H1N1 -- Swine Flu -- in our Territory. Nationwide, this will be the largest mass vaccination and immunization program in Canadian history.

Like many parents, my wife and I find ourselves struggling over whether or not to give our two-year-old son this H1N1 vaccine. We’re even wondering, Mr. Speaker, whether or not we should get the shot ourselves.

I want to be clear that the Department of Health and Social Services is doing a great job at providing information about H1N1, and their website and public...

Thank you, Mr. Speaker. My questions are for the Minister of Education, Culture and Employment.

How much money has the GNWT spent on the court action as it relates to Ecole Allain St-Cyr and the expansion of that school?

Thank you. Again, right off the product information leaflet, under elderly, it says no clinical data are available for Arepanrix H1N1 in this age group. Also, children aged from six months to 35 months, no clinical data available for influenza vaccines with ASO3 in this age group. So, Mr. Speaker, those are what is confusing to me and confusing to people.

I know I don’t have much time here, so I’d like to ask the Minister another question. In their H1N1 Slow the Spread information pamphlet that they have, they say the adjuvant in Canada’s H1N1 vaccine is made up of natural ingredients such as...

Thank you, Mr. Speaker. Today I want to speak about the Government of the Northwest Territories’ efforts in securing federal investment in our Territory. For four years we heard former Premier Joe Handley tell us the Deh Cho Bridge project was contingent on the federal government coming forward to help us pay for that bridge. We waited and waited for that investment and, obviously, none came and the government decided we would pay for it ourselves. Mr. Speaker, we will be paying for that bridge upwards of $4 million a year every year indexed for the next 35 years.

Mr. Speaker, why didn’t the...

Thank you, Mr. Speaker. I wish to report to the Assembly that the Standing Committee on Economic Development and Infrastructure has reviewed Bill 13, An Act to Amend the Commissioner’s Land Act. The committee wishes to report that Bill 13 is now ready for consideration in Committee of the Whole, as amended and reprinted. Thank you.

Thank you very much, Mr. Speaker. Thank you, Mr. Bromley. Questions were raised by a number of presenters on the sections of the act relating to habitat conservation provisions and the designation of habitat on private lands (s.79 and s.81). These concerns were primarily focused on whether the Minister could act unilaterally to designate habitat and how the rights of landowners were protected.

Departmental representatives explained that section 79 gives the Minister the authority to put forward regulations to protect habitat that is important to the conservation of any listed or pre-listed...

Thank you, Mr. Speaker. Over in the Yukon they’ve accessed $5 million of that Growing Forward Initiative money already and that was announced back in April. I guess what I’m trying to suggest to the government is we had better get on with this and put our proposals in, find the money, and try to leverage what dollars we have with the federal government’s dollars so that we can get some projects started here in the Northwest Territories. The question I have: Are we going to wait until the business plans in the fall before proposals such as Mr. McLeod might have are going to come forward in...